Methyl 4-methylpyrazolo[1,5-a]pyridine-3-carboxylate, 98.0%, 100mg

tert-Butyl 7-methyl-1,4-diazepane-1-carboxylate, 95.0%, 1g

2-amino-N,6-dimethyl-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide, 95.0%, 5g

Gallic acid monohydrate, min. 98%, pa, ACS, 250 g, plastic packaging.

(4aR,8aR)-Ethyl 7-oxooctahydro-2H-pyrano[3,2-c]pyridine-4a-carboxylate, 95%, 500mg

N-Acetyl-L-tryptophanamide, 95.0%, 250mg

5-Ethynyl-2,3-dimethylthiophene, 95%, 1g

Oxion OX.3035 Trinocular with Plan 4x/10x/S40x IOS objectives and Abbe condenser

2,4-Dichlorothiazole>98.0%(GC)5g

Methyl 3-fluoro-5-nitrobenzoate, 95.0%, 100g

3-(4-(Ethylthio)phenyl)-1-phenyl-1H-pyrazole-4-carbaldehyde, 100mg

ROTI®Pol TaqS, 500 µl, 5 x 100 µl